MicroRNAs (miRs) have emerged as cardiovascular biomarkers and myocardial regulators with diagnostic and therapeutic potential. 1 , 2 However, the miR profile of patients with hypertrophic cardiomyopathy (HCM) and miRs role in this genetic disease with heterogeneous phenotype 3 are incompletely determined. Here a multi‐step strategy provided evidence of differentially expressed miRs (DEmiRs) in plasma and myocardial tissue from HCM
Plasmatic and myocardial microRNA profiles in patients with hypertrophic cardiomyopathy / Lombardi, M., Lazzeroni, D., Benedetti, G., Bertoli, G., Lazarevic, D., Riba, M., De Cobelli, F., Rimoldi, O., D'Amati, G., Olivotto, I., Foglieni, C., Camici, P.. - In: CLINICAL AND TRANSLATIONAL MEDICINE. - ISSN 2001-1326. - 11:7(2021). [10.1002/ctm2.435]
Plasmatic and myocardial microRNA profiles in patients with hypertrophic cardiomyopathy
d'Amati, Giulia;
2021
Abstract
MicroRNAs (miRs) have emerged as cardiovascular biomarkers and myocardial regulators with diagnostic and therapeutic potential. 1 , 2 However, the miR profile of patients with hypertrophic cardiomyopathy (HCM) and miRs role in this genetic disease with heterogeneous phenotype 3 are incompletely determined. Here a multi‐step strategy provided evidence of differentially expressed miRs (DEmiRs) in plasma and myocardial tissue from HCM| File | Dimensione | Formato | |
|---|---|---|---|
|
Lombardi_Plasmatic and myocardial_2021.pdf
accesso aperto
Note: https://onlinelibrary.wiley.com/doi/full/10.1002/ctm2.435
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Creative commons
Dimensione
2.07 MB
Formato
Adobe PDF
|
2.07 MB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
